Cite Filings / SPRY / 0001950047-25-004740

Feed Companies Filings Check

Sign in

144

Sale of Securities

ARS Pharmaceuticals, Inc. Filed 2025-07-01 Acc 0001950047-25-004740

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2025-08-19 144 Sale of Securities
2025-07-03 4 Chief Commercial Officer sold 15,000 shares at $16.99 ($254,861)
2025-07-02 SCHEDULE 13D/A Beneficial Ownership Report
2025-07-01 144 Sale of Securities
2025-07-01 4 10% owner sold 740,149 shares at $18.46 ($13,663,151)
2025-06-27 4 Options or other derivatives
2025-06-18 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…